Gary Raskob to Thrombosis
This is a "connection" page, showing publications Gary Raskob has written about Thrombosis.
Connection Strength
2.288
-
Global Burden of Thrombosis: Epidemiologic Aspects. Circ Res. 2016 Apr 29; 118(9):1340-7.
Score: 0.472
-
On World Thrombosis Day. Lancet. 2014 Nov 08; 384(9955):1653-4.
Score: 0.426
-
On World Thrombosis Day. Lancet. 2014 Nov 08; 384(9955):1653-4.
Score: 0.426
-
Prevention of central venous catheter-associated thrombosis: a meta-analysis. Am J Med. 2007 Oct; 120(10):901.e1-13.
Score: 0.260
-
Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials. Thromb Haemost. 2020 Mar; 120(3):515-524.
Score: 0.153
-
Hirudin versus heparin and low-molecular-weight heparin: and the winner is... J Lab Clin Med. 1998 Sep; 132(3):171-4.
Score: 0.139
-
Oral anticoagulant therapy. Curr Opin Hematol. 1996 Sep; 3(5):361-4.
Score: 0.121
-
Thrombosis in Cancer: Research Priorities Identified by a National Cancer Institute/National Heart, Lung, and Blood Institute Strategic Working Group. Cancer Res. 2016 07 01; 76(13):3671-5.
Score: 0.119
-
Impedance plethysmography for suspected deep-vein thrombosis. Arch Intern Med. 1995 Apr 10; 155(7):773, 776.
Score: 0.110
-
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective. Arch Intern Med. 1997 Feb 10; 157(3):289-94.
Score: 0.031
-
Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective. Arch Intern Med. 1997 Feb 10; 157(3):298-303.
Score: 0.031